262 related articles for article (PubMed ID: 21890410)
1. mTOR: A pathogenic signaling pathway in developmental brain malformations.
Crino PB
Trends Mol Med; 2011 Dec; 17(12):734-42. PubMed ID: 21890410
[TBL] [Abstract][Full Text] [Related]
2. mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia.
Nguyen LH; Brewster AL; Clark ME; Regnier-Golanov A; Sunnen CN; Patil VV; D'Arcangelo G; Anderson AE
Epilepsia; 2015 Apr; 56(4):636-46. PubMed ID: 25752454
[TBL] [Abstract][Full Text] [Related]
3. Stromal liver kinase B1 [STK11] signaling loss induces oviductal adenomas and endometrial cancer by activating mammalian Target of Rapamycin Complex 1.
Tanwar PS; Kaneko-Tarui T; Zhang L; Tanaka Y; Crum CP; Teixeira JM
PLoS Genet; 2012; 8(8):e1002906. PubMed ID: 22916036
[TBL] [Abstract][Full Text] [Related]
4. PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma.
Roldan-Romero JM; Beuselinck B; Santos M; Rodriguez-Moreno JF; Lanillos J; Calsina B; Gutierrez A; Tang K; Lainez N; Puente J; Castellano D; Esteban E; Climent MA; Arranz JA; Albersen M; Oudard S; Couchy G; Caleiras E; Montero-Conde C; Cascón A; Robledo M; Rodríguez-Antona C; García-Donas J;
Int J Cancer; 2020 Mar; 146(5):1435-1444. PubMed ID: 31335987
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Mammalian Target of Rapamycin for Epileptic Encephalopathies and Malformations of Cortical Development.
Jeong A; Wong M
J Child Neurol; 2018 Jan; 33(1):55-63. PubMed ID: 29246093
[TBL] [Abstract][Full Text] [Related]
6. mTOR-dependent alterations of Kv1.1 subunit expression in the neuronal subset-specific Pten knockout mouse model of cortical dysplasia with epilepsy.
Nguyen LH; Anderson AE
Sci Rep; 2018 Feb; 8(1):3568. PubMed ID: 29476105
[TBL] [Abstract][Full Text] [Related]
7. Hyperactive mTOR signals in the proopiomelanocortin-expressing hippocampal neurons cause age-dependent epilepsy and premature death in mice.
Matsushita Y; Sakai Y; Shimmura M; Shigeto H; Nishio M; Akamine S; Sanefuji M; Ishizaki Y; Torisu H; Nakabeppu Y; Suzuki A; Takada H; Hara T
Sci Rep; 2016 Mar; 6():22991. PubMed ID: 26961412
[TBL] [Abstract][Full Text] [Related]
8. Before epilepsy unfolds: finding the epileptogenesis switch.
Vezzani A
Nat Med; 2012 Nov; 18(11):1626-7. PubMed ID: 23135516
[No Abstract] [Full Text] [Related]
9. Animal models of focal cortical dysplasia and tuberous sclerosis complex: recent progress toward clinical applications.
Wong M
Epilepsia; 2009 Oct; 50 Suppl 9(0 9):34-44. PubMed ID: 19761452
[TBL] [Abstract][Full Text] [Related]
10. Timing of mTOR activation affects tuberous sclerosis complex neuropathology in mouse models.
Magri L; Cominelli M; Cambiaghi M; Cursi M; Leocani L; Minicucci F; Poliani PL; Galli R
Dis Model Mech; 2013 Sep; 6(5):1185-97. PubMed ID: 23744272
[TBL] [Abstract][Full Text] [Related]
11. Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors.
Wagner AJ; Malinowska-Kolodziej I; Morgan JA; Qin W; Fletcher CD; Vena N; Ligon AH; Antonescu CR; Ramaiya NH; Demetri GD; Kwiatkowski DJ; Maki RG
J Clin Oncol; 2010 Feb; 28(5):835-40. PubMed ID: 20048174
[TBL] [Abstract][Full Text] [Related]
12. Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.
Lim JS; Gopalappa R; Kim SH; Ramakrishna S; Lee M; Kim WI; Kim J; Park SM; Lee J; Oh JH; Kim HD; Park CH; Lee JS; Kim S; Kim DS; Han JM; Kang HC; Kim HH; Lee JH
Am J Hum Genet; 2017 Mar; 100(3):454-472. PubMed ID: 28215400
[TBL] [Abstract][Full Text] [Related]
13. New insights into a spectrum of developmental malformations related to mTOR dysregulations: challenges and perspectives.
Mühlebner A; Bongaarts A; Sarnat HB; Scholl T; Aronica E
J Anat; 2019 Sep; 235(3):521-542. PubMed ID: 30901081
[TBL] [Abstract][Full Text] [Related]
14. mTOR in podocyte function: is rapamycin good for diabetic nephropathy?
Lu MK; Gong XG; Guan KL
Cell Cycle; 2011 Oct; 10(20):3415-6. PubMed ID: 22067710
[No Abstract] [Full Text] [Related]
15. Tuberous sclerosis complex.
Hasbani DM; Crino PB
Handb Clin Neurol; 2018; 148():813-822. PubMed ID: 29478616
[TBL] [Abstract][Full Text] [Related]
16. Impaired autophagy in neurons after disinhibition of mammalian target of rapamycin and its contribution to epileptogenesis.
McMahon J; Huang X; Yang J; Komatsu M; Yue Z; Qian J; Zhu X; Huang Y
J Neurosci; 2012 Nov; 32(45):15704-14. PubMed ID: 23136410
[TBL] [Abstract][Full Text] [Related]
17. Seizure-dependent mTOR activation in 5-HT neurons promotes autism-like behaviors in mice.
McMahon JJ; Yu W; Yang J; Feng H; Helm M; McMahon E; Zhu X; Shin D; Huang Y
Neurobiol Dis; 2015 Jan; 73():296-306. PubMed ID: 25315683
[TBL] [Abstract][Full Text] [Related]
18. mTOR signaling in epilepsy: insights from malformations of cortical development.
Crino PB
Cold Spring Harb Perspect Med; 2015 Apr; 5(4):. PubMed ID: 25833943
[TBL] [Abstract][Full Text] [Related]
19. Focal malformations of cortical development: new vistas for molecular pathogenesis.
Lim KC; Crino PB
Neuroscience; 2013 Nov; 252():262-76. PubMed ID: 23892008
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of cyclin D1 and phosphorylated ribosomal S6 proteins in hemimegalencephaly.
Aronica E; Boer K; Baybis M; Yu J; Crino P
Acta Neuropathol; 2007 Sep; 114(3):287-93. PubMed ID: 17483958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
